{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T17:16:57Z","timestamp":1697217417034},"reference-count":68,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T00:00:00Z","timestamp":1056067200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:p> <jats:italic>The main cardiovasoactive peptides involved in cardiovascular adaptation to renal failure and dialysis are reviewed with a special focus on their possible role in pathophysiology, diagnosis of cardiovascular and fluid volume abnormalities, and prognostic information.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>The role of vasoactive peptides in cardiovascular stability during hemodialysis (HD) are best seen in sequential HD, where the release of vasoconstrictors is stimulated by volume reduction during ultrafiltration, but is blunted during isovolemic HD, whereas plasma vasodilators increase.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Plasma levels of the natriuretic peptides atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are elevated in fluid volume overload and heart failure and decrease during dialysis. Neuropeptide Y (NPY) is elevated in severe volume overload and hypertension and calcitonin gene\u2010related peptide in large\u2010volume overload. Plasma BNP increases with left ventricular failure and improves during dialysis.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Activation of the sympathetic nervous system as reflected by increased plasma levels of NPY is associated with poor prognosis. High levels of the natriuretic peptides ANP and BNP are likewise predictors of poor prognosis.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Determinations of plasma levels of cardiovasoactive peptides may be helpful in clinical practice to diagnose volume overload and heart failure and to assess the severity of heart failure and of hypertension, as a guide to the choice of dialysis treatment and pharmacotherapy and to monitor treatment. Clinical studies will be needed in HD patients to establish the value of measurement of plasma cardiovasoactive peptides in clinical practice.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>The research in this field is still in its infancy and promises to be exciting in the future. There appears to be a balance of vasomotor tone and cardiac response to meet any emergency and stress such as intermittent dialysis. Further knowledge will increase our chances for major therapeutic interventions.<\/jats:italic> <\/jats:p>","DOI":"10.1046\/j.1492-7535.2003.00042.x","type":"journal-article","created":{"date-parts":[[2003,6,20]],"date-time":"2003-06-20T10:36:31Z","timestamp":1056105391000},"page":"222-231","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovasoactive Peptides in Hemodialysis Patients: Diagnostic Tools and Predictors of Outcome: A Review of Present Knowledge and Future Directions"],"prefix":"10.1111","volume":"7","author":[{"given":"I.","family":"Odar\u2010Cederl\u00f6f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Kjellstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,6,20]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90370-2"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91077-5"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/314264a0"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90351-4"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0710151"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91877-0"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150901"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(88)80080-8"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390507"},{"issue":"2","key":"e_1_2_9_11_2","first-page":"S72","article-title":"Ist der plasma\u2010ANP spiegel ein index fur die volume nexpansion bei dialyspatienten?","volume":"77","author":"Talarschik J","year":"1988","journal-title":"Z Kardiol."},{"issue":"3","key":"e_1_2_9_12_2","first-page":"188","article-title":"Effect of ultrafiltration on plasma concentration of atrial natriuretic peptide in haemodialysis patients","volume":"1","author":"Zoccali M","year":"1986","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"e_1_2_9_13_2","first-page":"303","article-title":"Cardiac function and cardiovascular hormone balance during hemodialysis with special reference to atrial natriuretic peptide","volume":"30","author":"Andersson U","year":"1988","journal-title":"Clin Nephrol."},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1989.tb01376.x"},{"issue":"2","key":"e_1_2_9_15_2","first-page":"153","article-title":"Fluid status in haemodialysed patients","volume":"10","author":"Leunissen KM","year":"1995","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"e_1_2_9_16_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/oxfordjournals.ndt.a091894","article-title":"Plasma alpha\u2010human atrial natriuretic peptide and volume status in chronic haemodialysis patients","volume":"4","author":"Leunissen KM","year":"1989","journal-title":"Nephrol Dial Transplant."},{"key":"e_1_2_9_17_2","first-page":"733(A","article-title":"Behaviour of vasoactive agents during hypotension in hemodialysis","volume":"7","author":"Odar\u2010Cederl\u00f6f I","year":"1992","journal-title":"Nephrol Dial Transplant."},{"key":"e_1_2_9_18_2","first-page":"356(A","article-title":"Does ANP reflect fluid overload in hemodialysis patients?","volume":"1","author":"Ericsson F","year":"1990","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201x.2001.00792.x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.supp2.28"},{"key":"e_1_2_9_21_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1681\/ASN.V4198","article-title":"Assessment of postdialysis dry weight: a comparison of techniques","volume":"4","author":"Kouw PM","year":"1993","journal-title":"J Am Society Nephrol."},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186362"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90309-1"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/332078a0"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115146"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.17.6.1152"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93126-L"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90401-4"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013385"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271508"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.113215"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02060-2"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0820127"},{"key":"e_1_2_9_34_2","first-page":"M2","article-title":"Brain natriuretic peptide (BNP) in plasma reflects left ventricular dysfunction in hemodialysis (HD) patients and decreases with daily dialysis","volume":"12","author":"Odar\u2010Cederl\u00f6f I","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/296659a0"},{"issue":"568","key":"e_1_2_9_36_2","first-page":"1","article-title":"Co\u2010release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control","volume":"133","author":"Pernow J","year":"1988","journal-title":"Acta Physiol Scand."},{"key":"e_1_2_9_37_2","first-page":"H1234","article-title":"Neuropeptide Y is a potent vasoconstrictor and cardiodepressant in rat","volume":"251","author":"Zukowska\u2010Grojec Z","year":"1987","journal-title":"Am J Physiol."},{"issue":"4","key":"e_1_2_9_38_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/oxfordjournals.eurheartj.a060526","article-title":"Prognostic value of plasma neuropeptide Y in coronary care unit patients with or without acute myocardial infarction","volume":"15","author":"Ullman B","year":"1994","journal-title":"Eur Heart J."},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90228-3"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/3.11.823"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb05472.x"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90483-1"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889301600907"},{"key":"e_1_2_9_44_2","first-page":"468(A","article-title":"Dual role of neuropeptide Y in hemodialysis patients","volume":"5","author":"Odar\u2010Cederl\u00f6f I","year":"1994","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000187215"},{"issue":"2","key":"e_1_2_9_46_2","first-page":"106","article-title":"Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis","volume":"41","author":"Hegbrant J","year":"1994","journal-title":"Clin Nephrol."},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(94)00206-L"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365599509180573"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70049-6"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90614-X"},{"key":"e_1_2_9_51_2","first-page":"227","article-title":"Antidiuretic hormone regulation in hemodialysis","volume":"37","author":"Odar\u2010Cederl\u00f6f I","year":"1991","journal-title":"ASAIO Trans."},{"key":"e_1_2_9_52_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/039139888901200304","article-title":"Plasma atrial natriuretic peptide, arginine vasopressin and hormones of the renin\u2010angiotensin system in patients with end\u2010stage renal disease","volume":"12","author":"Elias AN","year":"1989","journal-title":"Int J Artif Organs."},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"issue":"3","key":"e_1_2_9_54_2","first-page":"325","article-title":"Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi GM","year":"1994","journal-title":"Pharmacol Rev."},{"issue":"5","key":"e_1_2_9_55_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1681\/ASN.V1051037","article-title":"Hemodynamic effects of endothelin\u20101 and big endothelin\u20101 in chronic hemodialysis patients","volume":"10","author":"Ottosson\u2010Seeberger A","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92631-7"},{"issue":"6","key":"e_1_2_9_57_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/039139880102400608","article-title":"Influence of recombinant human erytheropoietin therapy on plasma endothelin\u20101 levels during hemodialysis","volume":"24","author":"Stefanidis I","year":"2001","journal-title":"Int J Artif Organs."},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33915"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00150.x"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/298240a0"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/308746a0"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02554909"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/313054a0"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889001300302"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1987.tb11382.x"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91035-S"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365599.1992.11690449"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199207000-00019"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200301000-00012"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1492-7535.2003.00042.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1492-7535.2003.00042.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1492-7535.2003.00042.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:38:15Z","timestamp":1697215095000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1492-7535.2003.00042.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1046\/j.1492-7535.2003.00042.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1492-7535.2003.00042.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}